Oxytocic Pharmaceuticals Market: Labour Induction Segment Expected to Register Moderate Y-o-Y Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 - 2026

  • Published: 2017-01-17
  • Report Code: REP-GB-1445

An Incisive, In-depth Analysis on the Oxytocic Pharmaceuticals Market

This study offers a comprehensive, 360 degree analysis on the Oxytocic Pharmaceuticals market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Oxytocic Pharmaceuticals market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

With a CAGR of 10.1%, the post-partum haemorrhage segment anticipated to lead the global oxytocic pharmaceuticals market in the coming decade

The post-partum haemorrhage segment was estimated to account for more than 75% market share of the global oxytocic pharmaceuticals market by the end of 2016 and is expected to gain more than 200 BPS in its market share by 2026. The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period. The post-partum haemorrhage segment is estimated to create absolute $ opportunity of more than US$ 5 Mn in 2017 over 2016. This segment dominated the global oxytocic pharmaceuticals market in terms of revenue in 2015, and the trend is projected to continue throughout the period of forecast.

Labour induction during childbirth is likely to boost the post-partum haemorrhage segment

Increasing childbirth using labour induction proves to be driving factor for the post-partum haemorrhage condition. There are certain situations – for instance, pre-eclampsia – where continuing the pregnancy is dangerous to the mother, or there are instances where women are uncomfortable, sore and tired. In such cases, labour is induced for convenience rather than medical reasons. However, labour induction increases the chances of post-partum haemorrhage. According to the World Health Organization, the rate of labour induction in developing countries is lower; but in developed countries, the rates are relatively high, which is creating a positive impact on the post-partum haemorrhage segment. Another factor which is likely to fuel the revenue growth of the post-partum haemorrhage segment is the increasing age of mothers. Older and heavier women and women who are smokers are more likely to bleed heavily after delivery. The ratio of getting pregnant after a certain age in life has increased in almost all the regions across the globe and this is creating robust development in the global oxytocic pharmaceuticals market, and specifically in the post-partum haemorrhage segment.

oxytocic pharmaceuticals market_Image for preview analysis

Africa’s contribution to the prevalence of post-partum haemorrhage is likely to increase due to lack of healthcare infrastructure and awareness regarding pregnancy

The post-partum haemorrhage segment is the most attractive segment by indication in the North America oxytocic pharmaceuticals market, with a market attractiveness index of 3.9 estimated during the forecast period. In the Latin America region, the post-partum haemorrhage segment is estimated to reach a market attractiveness index of 3.7 due to increasing adolescent pregnancies. A majority of these pregnancies occur in Brazil in Latin America. An increase in labour induction procedures in the region is responsible for positioning post-partum haemorrhage as the most attractive indication segment. The MEA region represents a higher prevalence of post-partum haemorrhage among all the regions owing to lack of proper nutrition to pregnant women. Africa’s contribution to the prevalence of post-partum haemorrhage in the MEA region is on the higher end, owing to a lack of healthcare infrastructure and awareness regarding pregnancy related aspects among African women. Prevalence of post-partum haemorrhage is as high as 25.7% in African countries and 8.5% in Asian countries. In China, the post-partum haemorrhage segment is anticipated to record a market attractiveness index of 3.8 during the forecast period. A large pool of population and China’s altered single child policy to two children policy may likely increase the incidence of post-partum haemorrhage. 

Opportunities in the global oxytocic pharmaceuticals market owing to rising instances of post-partum haemorrhage 

Companies functioning in the global oxytocic pharmaceuticals market can reap larger market revenue from untapped markets in Asia and Africa where the prevalence of post-partum haemorrhage is on the higher side in comparison with other regions. Imparting awareness pertaining to pregnancy among the women in these regions can help create more market opportunities for existing as well as new entrants in the global oxytocic pharmaceuticals market.

“Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2016-2026,” a recently published report by Future Market Insights, examines the global oxytocic pharmaceuticals market scenario for a 10-year forecast period. The key objective of this report is to provide information on market dynamics and opportunities for manufacturers operating in the global oxytocic pharmaceuticals market. While researching this report, our analysts have considered overall market approach and have come to a conclusion that companies in the global oxytocic pharmaceuticals market are mainly focussing on geographic expansion and product differentiation to gain a larger market share. Our analysts have further targeted the different geographies and found that the presence of a large patient pool and an increase in healthcare expenditure are promising factors for investors to invest in the global oxytocic pharmaceuticals market. While studying differentiating market strategies, we have observed that companies are targeting the Asia Pacific and MEA regions by means of distribution agreements with local players and are increasing their field force to reach out to prospective customers.  

Through extensive research, our analysts have thoroughly studied the global oxytocic pharmaceuticals market and have identified multiple drivers, restraints, trends and opportunities that are expected to influence the global oxytocic pharmaceuticals market and consequently the business operations of the leading as well as second-in-line players functioning in the global oxytocic pharmaceuticals market. Our analysts have further studied how the different market dynamics are likely to impact the current environment and future scenario of the global oxytocic pharmaceuticals market, thereby providing useful insights to market players to plan their strategies capable of evolving with the changing market landscape. 

Report Description

Future Market Insights’ report provides a comprehensive picture of the global oxytocic pharmaceuticals market and covers market performance in terms of revenue. The report also comprises an analysis of drivers and restraints from the supply and demand sides followed by the global trends and opportunities in the global oxytocic pharmaceuticals market. The report has taken a deep dive into the various segments, including regions and has presented an unbiased and independent analysis of various factors dominating each segment and sub-segment in this detailed report on the global oxytocic pharmaceuticals market.

Macro-economic indicators such as healthcare industry outlook, healthcare spending, the prevalence of cancer, and Gross Domestic Product have been considered to arrive at the indicated market numbers. The report considers prevention and treatment doses for post-partum haemorrhage conditions in the study along with labour induction, labour arrest, and abortion induced incomplete and inevitable abortion conditions. Lastly, the report covers the global oxytocic pharmaceuticals market competitive landscape and provides a dashboard view of companies that provide services in the global oxytocic pharmaceuticals market. The report includes company profiles of some of the key players operating in the global oxytocic pharmaceuticals market and a strategic overview of mergers and acquisitions dotting the global oxytocic pharmaceuticals landscape.

To understand and assess the opportunities in the global oxytocic pharmaceuticals market, the report is categorically split into five sections based on market segmentation.

By Indication

By Route of administration

By Source of Origin

By End-User

By Region

  • Abortion Induced Incomplete

  • Inevitable Abortion

  • Post-partum Haemorrhage

  • Labour Induction

  • Labour Arrest

 

  • Intravenous Infusion/Injection

  • Intramuscular Injection

 

  • Natural Oxytocin

  • Synthetic Oxytocin Derivative

  • Hospitals

  • Maternity clinics

 

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • Asia Pacific Excluding Japan and China (APEJC)

  •  Japan

  • China

  • Middle East & Africa (MEA)

Our exclusive research methodology

The forecast presented in our report on the global oxytocic pharmaceuticals market assesses the total revenue generated in the global oxytocic pharmaceuticals market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome based on an analysis of supply side and demand side dynamics. For quantifying market numbers, we have conducted interviews with subject matter experts in the global oxytocic pharmaceuticals market.

In addition, we have taken into consideration the year-on-year growth of different segments to understand the predictability of the market and to identify the right growth opportunities in the global oxytocic pharmaceuticals market. All the segments or categories have been analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends governing the global oxytocic pharmaceuticals market. Another key feature of our report is the analysis of the global oxytocic pharmaceuticals market based on indication, route of administration, source of origin, end user and region; and the market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that providers can look to achieve, as well as to identify potential resources from a sales perspective in the global oxytocic pharmaceuticals market.

Oxytocic Pharmaceuticals Market Reports - Table of Contents

Oxytocic Pharmaceuticals Market Reports - List of Tables

Table 1: Global Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 2: Global Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 3: North America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 4: North America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 5: Latin America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 6: Latin America Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 7: Western Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 8: Western Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 9: Eastern Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 10: Eastern Europe Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 11: China Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 12: China Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 13: Japan Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 14: Japan Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 15: APEJC Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 16: APEJC Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 17: MEA Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by Region, 2015–2026

Table 18: MEA Oxytocic Pharmaceuticals Market Volume (In Thousands) Analysis and Forecast by End User, 2015–2026

Table 19: Global Cervical Ripening Procedures Market Volume (In Thousands) Analysis by Region, 2015

Table 20: Comparative drugs for controlling PPH conditions

Table 21: Comparative drugs for controlling PPH conditions

Table 22: Comparative drugs for controlling PPH conditions

Table 23: Comparative drugs for controlling PPH conditions

Table 24: Comparative drugs for controlling PPH conditions

Table 25: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2016 – 2026

Table 26: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2016 – 2026

Table 27: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 28: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 29: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Region, 2015–2026

Table 30: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 31: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 32: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 33: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 34: North America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 35: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 36: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 37: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 38: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 39: Latin America Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 40: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 41: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 42: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 43: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 44: Western Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 45: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 46: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 47: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 48: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 49: Eastern Europe Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 50: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 51: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 52: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 53: China Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 54: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 55: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 56: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 57: Japan Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 58: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 59: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 60: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 61: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 62: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 63: APEJC Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Table 64: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Country, 2015–2026

Table 65: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Indication, 2015 – 2026

Table 66: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Route of Administration, 2015 – 2026

Table 67: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by Source of Origin, 2015 – 2026

Table 68: MEA Oxytocic Pharmaceuticals Market Value (US$ Mn) Analysis and Forecast by End User, 2015–2026

Oxytocic Pharmaceuticals Market Reports - List of Figures

Figure 01: Global Oxytocic Pharmaceuticals Market Value Share By, Indication, 2016

Figure 02: Global Oxytocic Pharmaceuticals Market Value Share By, Source of Origin, 2016

Figure 03: Global Oxytocic Pharmaceuticals Market Value Share By, Route of Administration, 2016

Figure 04: Global Oxytocic Pharmaceuticals Market Value Share By, Region, 2016

Figure 05: Global Oxytocic Pharmaceuticals Market Value (US$ Mn) Forecast, 2015–2026 

Figure 06: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity, 2015–2026 

Figure 07: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth, 2015–2026 

Figure 08: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Indication, 2016 - 2026

Figure 09: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Indication, 2016–2026 

Figure 10: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by abortion induced incomplete Segment, 2016 – 2026

Figure 11: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by inevitable abortion Segment, 2015 – 2026

Figure 12: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by post-partum hemorrhage Segment, 2015 – 2026

Figure 13: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor induction Segment, 2015 – 2026

Figure 14: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor arrest Segment, 2015 – 2026

Figure 15: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) by labor arrest Segment, 2015 – 2026

Figure 16: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016–2026 

Figure 17: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Route of Administration, 2016- 2026

Figure 18: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Route of Administration, 2016–2026 

Figure 19: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Intramuscular

Figure 20: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Intravenous Injection/Infusion Segment, 2015 – 2026

Figure 21: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Source of Origin, 2016- 2026

Figure 22: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Source of Origin, 2016–2026 

Figure 23: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Synthetic Oxytocin, 2015 – 2026

Figure 24: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Natural Oxytocin Segment, 2015 – 2026

Figure 25: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016–2026 

Figure 26: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By End User, 2016, 2026

Figure 27: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By End User, 2015–2026 

Figure 28: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Hospitals Segment, 2015 – 2026

Figure 29: Global Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn) By Maternity Centers Segment, 2015 – 2026

Figure 30: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016–2026 

Figure 31: Global Oxytocic Pharmaceuticals Market Share Analysis (%) By Region, 2016, 2026

Figure 32: Global Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Region, 2015–2026 

Figure 33: North America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 34: Latin America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 35: Western Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 36: Eastern Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 37: APEJC Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 38: Japan Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 39: MEA Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 40: China Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 41: Global Oxytocic Pharmaceuticals Market Attractiveness Analysis by Region, 2016–2026 

Figure 42: North America Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 43: North America Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 44: The U.S. Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 45: Canada Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 46: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 47: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 48: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 49: North America Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 50: Latin America Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 51: Latin America Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 52: The Brazil Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 53: Mexico Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 54: The Rest of Latin America Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 55: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 56: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 57: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 58: Latin America Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 59: Western Europe Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 60: Western Europe Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 61: Germany Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 62: France Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 63: Italy Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 64: Spain Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 65: U.K. Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 66: BENELUX Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 67: The Rest of Western Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 68: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 69: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 70: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 71: Western Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 72: Eastern Europe Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 73: Eastern Europe Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 74: Russia Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 75: Poland Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 76: The Rest of Eastern Europe Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 77: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 78: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 79: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 80: Eastern Europe Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 81: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Route of Administration, 2016 – 2026 

Figure 82: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 83: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 84: China Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 85: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Route of Administration, 2016 – 2026 

Figure 86: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 87: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 88: Japan Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 89: APEJC Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 90: APEJC Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 91: India Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 92: ASEAN Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 93: Australia & New Zealand Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 94: Rest of APEJC Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 95: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 96: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 97: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 98: APEJC Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Figure 99: MEA Oxytocic Pharmaceuticals Market Share Analysis (%) By Country, 2016, 2026

Figure 100: MEA Oxytocic Pharmaceuticals Market Y-o-Y Growth (%) By Country, 2015–2026 

Figure 101: GCC Countries Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 102: South Africa Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 103: The Rest of MEA Oxytocic Pharmaceuticals Market Absolute $ Opportunity (US$ Mn), 2015 – 2026

Figure 104: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Country, 2016 – 2026 

Figure 105: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Indication, 2016 – 2026

Figure 106: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by Source of Origin, 2016 – 2026

Figure 107: MEA Oxytocic Pharmaceuticals Market Attractiveness Analysis by End User, 2016 – 2026

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology